Opendata, web and dolomites


ICT platform to reduce mortality rates for Transcatheter Aortic Valve Implantation (TAVI) by pre-operative risk management

Total Cost €


EC-Contrib. €






 TAVIguide project word cloud

Explore the words cloud of the TAVIguide project. It provides you a very rough idea of what is the project "TAVIguide" about.

therapy    positive    provides    beneficial    fast    model    fda    12    patients    manufacturers    tavi    optimize    platform    heart    feasibility    personalized    software    2014    license    vii    pillar    service    approval    patient    groups    population    fee    prospective    complications    validation    tackle    enabled    society    health    offerings    prepare    solution    quality    verified    preparation    blood    plus    simulation    2025    our    huge    taviguide    disruptive    economic    centres    mitral    25    innovative    selling    found    2021    ageing    medical    elaborated    distinctly    commercialization    4b    lt    device    stakeholders    operative    proposition    rates    care    4x    ict    mortality    offers    accurate    mitigate    sustainable    healthcare    business    give       risk    flow    benefits    competitive    valve    market    implantation    size    marketing    groundbreaking    correctly    3d    entry    share    reducing    global    grow    procedure    analysed    surgeons    disease    aortic    plan       additional    physicians    trade    revenue    thanks    digital    thereby    7b   

Project "TAVIguide" data sheet

The following table provides information about the project.


Organization address
city: GENT
postcode: 9052
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2016-04-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FEOPS NV BE (GENT) coordinator 50˙000.00


 Project objective

Our market disruptive TAVIguide™ ICT solution (a Software-as-a-Service platform) will be distinctly beneficial for the global healthcare system with a positive impact on two main groups: a favourable economic impact for medical centres and physicians and an improved quality of care and experience for patients. Our ICT platform addresses an innovative digital health ICT concept and service and will help to tackle the society's challenge of growing needs for sustainable and personalized healthcare (ICT Pillar VII “ICT-enabled benefits for EU society”). It provides surgeons with a groundbreaking ICT solution thanks to beyond State-of-the-Art patient-specific 3D heart modelling and blood flow simulation for pre-operative analysis and preparation of aortic valve implantation. These unique features, not found in competitive offerings, allow to correctly assess and mitigate the complications risk, thereby reducing mortality rates across all TAVI patients from up to 25% after 1 year to <5%. Our TAVIguide™ platform offers a huge potential to device manufacturers who can use the accurate modelling and simulation features to further optimize their TAVI devices and prepare the way for patient-specific valve design. Our business concept is based on a software license revenue model plus fee per case. FDA approval and validation in a prospective patient study during Phase 2 will give us a unique selling proposition for different TAVI stakeholders. Commercialization of TAVIguide™ is planned on a global scale (EU and US). Due to the growing medical importance of the TAVI procedure and an ageing population, the target TAVI market is expected to grow from 1.4B€ (2014) to 4.7B€ (2025). We aim for a 12.6% share by 2021. An additional market entry for mitral valve disease therapy, 4x the TAVI market size, will be analysed. The elaborated business plan and verified technical and marketing feasibility for additional medical applications will prepare our solution for fast market uptake.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TAVIGUIDE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TAVIGUIDE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Starcounter (2017)

In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise Software

Read More  

oWBI (2018)

Osmotic Wearable Bolus Injector (oWBI) for viscous drug delivery

Read More  


SME LOYALISER: fostering SME retailers through LOYALty Integrated SERvices

Read More